Page 34 - Human Use News Today

By Colin Kellaher Bayer on Friday said the European Medicines Agencys Committee for Medicinal Products for Human Use has recommended approval of a high-dose formulation of the blockbuster eye...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of pembrolizumab (Keytruda) combined with gemcitabine and cisplatin in the frontline treatment of adult patients with locally advanced unresectable or metastatic biliary tract cancer

UCB receives CHMP positive opinion for rozanolixizumab for treatment of adults with generalized myasthenia gravis in Europe The Committee for Medicinal...

Advances in artificial intelligence, many coming from California companies, have led to new possibilities for life and work. However, concerns about its potential power persist as tech companies expand its capabilities.

Hong Kong: HK accepted as observer by int'l body

Hong Kong has been accepted as an observer of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for ...

BARCELONA, Spain, November 09, 2023--Almirall, S.A. (ALM), the global biopharmaceutical company based in Barcelona, has announced its 9M 2023.

Almirall achieves Net Sales growth of 6.4%, driven by strong European dermatology performanceAlmirall's European Dermatology business continued to be the driving force behind Almirall's strong performance in the first nine months of 2023, with a growth rate of 15.9% underpinned by the success of Ilumetri® and other...

Hong Kong: Health chief calls on drug authority

          Received 430 new patient start forms for FILSPARI®  in the third quarter of 2023; demand and payer coverage continued to grow             Net product sales of FILSPARI...